GW Henssler & Associates’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-1,022
Closed -$206K – 232
2020
Q4
$206K Buy
1,022
+10
+1% +$2.07K 0.02% 221
2020
Q3
$213K Buy
1,012
+44
+5% +$9.8K 0.02% 196
2020
Q2
$212K Sell
968
-1,231
-56% -$246K 0.02% 178
2020
Q1
$381K Sell
2,199
-20
-0.9% -$3.3K 0.04% 123
2019
Q4
$341K Buy
+2,219
New +$332K 0.03% 180
2018
Q1
– Sell
-1,406
Closed -$209K – 133
2017
Q4
$209K Buy
+1,406
New +$191K 0.02% 139
2016
Q3
– Sell
-1,448
Closed -$200K – 144
2016
Q2
$200K Buy
+1,448
New +$188K 0.02% 137
2016
Q1
– Sell
-1,777
Closed -$225K – 151
2015
Q4
$225K Sell
1,777
-757
-30% -$94K 0.03% 147
2015
Q3
$293K Sell
2,534
-34
-1% -$3.82K 0.03% 133
2015
Q2
$267K Buy
+2,568
New +$277K 0.03% 135
2015
Q1
– Sell
-2,618
Closed -$273K – 171
2014
Q4
$273K Hold
2,618
– – 0.03% 136
2014
Q3
$251K Sell
2,618
-355
-12% -$32.1K 0.03% 129
2014
Q2
$272K Sell
2,973
-801
-21% -$71.7K 0.03% 126
2014
Q1
$332K Sell
3,774
-686
-15% -$60.2K 0.04% 128
2013
Q4
$414K Sell
4,460
-1
-0% -$90 0.05% 119
2013
Q3
$365K Sell
4,461
-156
-3% -$13.2K 0.05% 117
2013
Q2
$384K Buy
+4,617
New +$397K 0.05% 117

Other funds holding CLX

GW Henssler & Associates's CLX Position: Q1 2021 in Review

GW Henssler & Associates sold out of Clorox (CLX) in Q1 2021, closing a stake of 1,022 shares — an estimated $206K sold.

GW Henssler & Associates first reported a position in CLX in Q2 2013 and held it in 17 quarters. The position peaked at $414K in Q4 2013. 1,207 funds tracked by Wall St. Rank hold CLX as of Q1 2021.

  • GW Henssler & Associates reported no remaining Clorox position as of Q1 2021 after selling out during the quarter.
  • GW Henssler & Associates sold 1,022 Clorox shares in Q1 2021, an estimated $206K.
  • GW Henssler & Associates first reported a position in Clorox in Q2 2013 and held it in 17 quarters.
  • GW Henssler & Associates's Clorox position peaked at $414K in Q4 2013.
  • 1,207 funds tracked by Wall St. Rank held Clorox as of Q1 2021.

Based on GW Henssler & Associates's 13F filing for Q1 2021, filed 28 Apr 2021.